Archives

A Primer On The End-Stage Renal Diseases Treatment Choices (ETC) Model
Implementation of the End-Stage Renal Disease Treatment Choices (ETC) Model began on January 1, 2021. In this informative webinar, Mark Neumann and Amy Kozsuch discuss the details of this payment model and how it impacts providers across the End-Stage Renal Disease care spectrum.
*Amy Kozsuch and Mark Neumann are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Aaron Emmel is an employee of OPDC.
If you would like to register for the 6:00 pm to 7:00 pm EDT broadcast, please click below:
Featured Speakers

Amy Kozsuch, MSN, MBA
-
Health Map Solutions*
Amy Kozsuch is the Vice President of Clinical Products at Healthmap. In this role she is responsible for expanding and developing innovative programs that advance early detection of chronic kidney disease, defer its progression, and deliver improved patient outcomes at lower costs. Amy has 30 years of experience in the kidney health industry, having worked as a nurse administrator, director of clinical operations and corporate development in the past. She serves on several health industry board of directors, most recently as executive board president for the National Kidney Foundation of Florida. Amy earned her MSN, MBA, and Health Care Administration degrees from University of Phoenix, where she is currently a doctoral candidate.

Mark Neumann
-
Healthcare Writer & Editor*
Mark Neumann started his career as a healthcare writer and editor in 1984 and has been covering clinical, regulatory, and economic issues in the kidney care field for the past 30 years. He is a previous winner of the President’s Award from the National Association of Nephrology Technicians and Technologists and a Medal of Excellence Award winner from the American Association of Kidney Patients.
Moderator

Aaron Emmel, PharmD, MHA, BCPS
Location
Online